Skip to main content
. 2017 Nov 15;18(4):1470320317739987. doi: 10.1177/1470320317739987

Table 3.

Comparison of ACE I/D and MMPs genotypes’ distribution among STEMI, NSTEMI and control group patients.

Genotypes All patients with ACS
n (%)
STEMI
n (%)
NSTEMI
n (%)
Control group
n (%)
ACE I/D
II 117 (22.5) 89 (22.8) 28 (21.7) 165 (25.6)
ID 317 (61.1)* 236 (60.5)* 81 (62.8)* 339 (52.6)
DD 85 (16.4)* 65 (16.7)* 20 (15.5)* 141 (21.9)
ID + II 434 (83.6)* 325 (83.3)* 109 (84.5) 504 (78.1)
DD 85 (16.4) 65 (16.7) 20 (15.5) 141 (21.9)
MMP-2 –735 C/T
CC 412 (79.4) 306 (78.7) 106 (81.5) 504 (78.1)
CT 100 (19.3) 78 (20.1) 22 (16.9) 126 (19.5)
TT 7 (1.3) 5 (1.3) 2 (1.5) 15 (2.3)
TT + CT 107 (20.6) 83 (21.3) 24 (18.5) 141 (21.9)
CC 412 (79.4) 307 (78.7) 106 (81.5) 504 (78.1)
MMP-2 –1306 C/T
CC 312 (59.9) 235 (60.1) 77 (59.2) 369 (57.2)
CT 175 (33.6) 130 (33.2) 45 (34.6) 237 (36.7)
TT 34 (6.5) 26 (6.6) 8 (6.2) 39 (6.0)
CC + CT 487 (93.5) 366 (93.4) 122 (93.8) 606 (94.0)
TT 34 (6.5) 26 (6.6) 8 (6.2) 39 (6.0)
MMP-3 5A/6A
5A5A 145 (27.7)* 114(29.0)*# 31 (23.8)# 151 (23.4)
5A6A 269 (51.4) 206 (52.4) 63 (48.5) 325 (50.4)
6A6A 109 (20.8)* 73 (18.6)*# 36 (27.7)# 169 (26.2)
5A5A + 5A6A 414 (79.2)* 321 (81.5)*# 94 (72.3)# 475 (73.6)
6A6A 109 (20.8) 73 (18.5) 36 (27.7) 170 (26.4)
MMP-9 C/T
TT 22 (4.2) 17 (4.4) 5 (3.8) 29 (4.5)
CT 156 (30.1) 113 (29.1) 43 (33.1) 185 (28.7)
CC 340 (65.6) 258 (66.5) 82 (63.1) 431 (66.8)
TT + CT 178 (34.4) 131 (33.7) 48 (36.9) 214 (33.2)
CC 340 (65.6) 258 (66.3) 82 (63.1) 431 (66.8)
*

P<0.05 if comparing between ACS patients (STEMI and/or NSTEMI) and control group.

#

P<0.005 if comparing between STEMI and NSTEMI patients. ACE: angiotensin converting enzyme; ACS: acute coronary syndrome; STEMI: ST elevation myocardial infarction; NSTEMI: non-ST elevation myocardial infarction; I: insertion; D: deletion; MMP: matrix metalloproteinase; T: thymine; C: cytosine; A: adenine.